Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma

Pancreas

Volumn 45, Issue 1, 2016, Pages 71-83

  Kuo, Kung Kai ^a,b,c   Kuo, Chao Jen ^c   Chiu, Chiang Yen ^a   Liang, Shih Shin ^c,d   Huang, Chun Hao ^e   Chi, Shu Wen ^c   Tsai, Kun Bow ^f   Chen, Chiao Yun ^a,g   Hsi, Edward ^g   Cheng, Kuang Hung ^h   Chiou, Shyh Horng ^c,i  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Center for Stem Cell Research   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d State Key Laboratory of Crop Biology   (Taiwan)

^e Weill Cornell Graduate School of Biomedical Sciences   (United States)

^f KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^h NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

ⁱ INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

nano liquid chromatography coupled tandem mass spectrometry; pancreatic ductal adenocarcinoma; quantitative proteomics; shotgun proteomics analysis; stable isotope dimethyl labeling

Indexed keywords

ALPHA CATENIN; ALPHA ENOLASE; CALCYCLIN; CALMODULIN; EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT F; GALECTIN 1; K RAS PROTEIN; LIPOCORTIN 1; PROTEIN 14 3 3; PROTEIN 14 3 3 BETA; PROTEIN P53; TUBULIN ALPHA 1A CHAIN; UNCLASSIFIED DRUG; VIMENTIN; VOLTAGE DEPENDENT ANION CHANNEL 1; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENOTYPE; HISTOCHEMISTRY; HYDROPHILIC INTERACTION CHROMATOGRAPHY; IMMUNOFLUORESCENCE; LIQUID CHROMATOGRAPHY; MALE; MOUSE; NANO LIQUID CHROMATOGRAPHY COUPLED TANDEM MASS SPECTROMETRY; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREATIC TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; START CODON; TANDEM MASS SPECTROMETRY; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOLOGY; CANCER STAGING; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; ISOTOPE LABELING; METABOLISM; NANOTECHNOLOGY; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PEPTIDE MAPPING; PHENOTYPE; PROCEDURES; PROTEIN DATABASE; PROTEIN PROTEIN INTERACTION; TIME FACTOR; TRANSGENIC MOUSE;

ANIMALS; BIOMARKERS, TUMOR; CARCINOMA, PANCREATIC DUCTAL; CHROMATOGRAPHY, LIQUID; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; ISOTOPE LABELING; MICE; MICE, TRANSGENIC; NANOTECHNOLOGY; NEOPLASM PROTEINS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PEPTIDE MAPPING; PHENOTYPE; PROTEIN INTERACTION MAPS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 84952705707     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000388     Document Type: Article

References (57)

1. Jemal A, Siegel R, Xu J, Cancer statistics, 2010. CA Cancer J Clin. 2010; 60: 277-300.
2. Li D, Xie K, Wolff R, Pancreatic cancer. Lancet. 2004; 363: 1049-1057.
3. DiGiuseppe JA, Hruban RH, Offerhaus GJ, Detection of K- ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol. 1994; 144: 889-895.
4. Gidekel Friedlander SY, Chu GC, Snyder EL, Context-dependent transformation of adult pancreatic cells by oncogenic K- ras. Cancer Cell. 2009; 16: 379-389.
5. Hruban RH, Wilentz RE, Kern SE,. Genetic progression in the pancreatic ducts. Am J Pathol. 2000; 156: 1821-1825.
6. van Heek NT, Meeker AK, Kern SE, Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol. 2002; 161: 1541-1547.
7. Maitra A, Fukushima N, Takaori K, Precursors to invasive pancreatic cancer. Adv Anat Pathol. 2005; 12: 81-91.
8. Zhu L, Shi G, Schmidt CM, Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am J Pathol. 2007; 171: 263-273.
9. De La O JP, Emerson LL, Goodman JL, Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci U S A. 2008; 105: 18907-18912.
10. Habbe N, Shi G, Meguid RA, Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci U S A. 2008; 105: 18913-18918.
11. Kern SE, Shi C, Hruban RH,. The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting. J Pathol. 2011; 223: 295-306.
12. Adesso L, Calabretta S, Barbagallo F, Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/EIF4E pathway. Oncogene. 2013; 32: 2848-2857.
13. Egawa S, Toma H, Ohigashi H, Japan pancreatic cancer registry; 30th year anniversary: Japan pancreas society. Pancreas. 2012; 41: 985-992.
14. Chiou SH, Wu CY,. Clinical proteomics: current status, challenges, and future perspectives. Kaohsiung J Med Sci. 2011; 27: 1-14.
15. Ideker T, Thorsson V, Ranish JA, Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science. 2001; 292: 929-934.
16. Washburn MP, Wolters D, Yates JR 3rd,. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol. 2001; 19: 242-247.
17. McCormack AL, Schieltz DM, Goode B, Direct analysis and identification of proteins in mixtures by LC/MS/MS and database searching at the low-femtomole level. Anal Chem. 1997; 69: 767-776.
18. MacCoss MJ, McDonald WH, Saraf A, Shotgun identification of protein modifications from protein complexes and lens tissue. Proc Natl Acad Sci U S A. 2002; 99: 7900-7905.
19. Wu CJ, Chen YW, Tai JH, Quantitative phosphoproteomics studies using stable isotope dimethyl labeling coupled with IMAC-HILIC-NANOLC-MS/MS for estrogen-induced transcriptional regulation. J Proteome Res. 2011; 10: 1088-1097.
20. Santos HM, Kouvonen P, Capelo JL, Isotopic labelling of peptides in tissues enhances mass spectrometric profiling. Rapid Commun Mass Spectrom. 2012; 26: 254-262.
21. Boersema PJ, Aye TT, van Veen TA, Triplex protein quantification based on stable isotope labeling by peptide dimethylation applied to cell and tissue lysates. Proteomics. 2008; 8: 4624-4632.
22. Jackson EL, Willis N, Mercer K, Analysis of lung tumor initiation and progression using conditional expression of oncogenic K- ras. Genes Dev. 2001; 15: 3243-3248.
23. Yoshida T,. Peptide separation in normal phase liquid chromatography. Anal Chem. 1997; 69: 3038-3043.
24. Yoshida T,. Calculation of peptide retention coefficients in normal-phase liquid chromatography. J Chromatogr A. 1998; 808: 105-112.
25. Alpert AJ,. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J Chromatogr. 1990; 499: 177-196.
26. Perkins DN, Pappin DJ, Creasy DM, Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999; 20: 3551-3567.
27. Hirosawa M, Hoshida M, Ishikawa M, MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci. 1993; 9: 161-167.
28. Bardeesy N, Cheng KH, Berger JH, Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 2006; 20: 3130-3146.
29. Badea L, Herlea V, Dima SO, Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology. 2008; 55: 2016-2027.
30. Rachagani S, Torres MP, Kumar S, Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. J Hematol Oncol. 2012; 5: 68.
31. Zhao X, Gao S, Ren H, Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. Cancer Res. 2014; 74: 2455-2464.
32. Thingholm TE, Jensen ON, Robinson PJ, SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol Cell Proteomics. 2008; 7: 661-671.
33. Hou W, Ethier M, Smith JC, Multiplexed proteomic reactor for the processing of proteomic samples. Anal Chem. 2007; 79: 39-44.
34. Pichler P, Kocher T, Holzmann J, Peptide labeling with isobaric tags yields higher identification rates using iTRAQ 4-plex compared to TMT 6-plex and iTRAQ 8-plex on LTQ Orbitrap. Anal Chem. 2010; 82: 6549-6558.
35. Webster J, Oxley D,. Protein identification by maldi-tof mass spectrometry. Methods Mol Biol. 2012; 800: 227-240.
36. Shi G, DiRenzo D, Qu C, Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia. Oncogene. 2013; 32: 1950-1958.
37. Unwin RD, Craven RA, Harnden P, Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics. 2003; 3: 1620-1632.
38. Craven RA, Stanley AJ, Hanrahan S, Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics. 2006; 6: 2853-2864.
39. Wu CJ, Hsu JL, Huang SY, Mapping n-terminus phosphorylation sites and quantitation by stable isotope dimethyl labeling. J Am Soc Mass Spectrom. 2010; 21: 460-471.
40. Huang SY, Tsai ML, Wu CJ, Quantitation of protein phosphorylation in pregnant rat uteri using stable isotope dimethyl labeling coupled with IMAC. Proteomics. 2006; 6: 1722-1734.
41. Ying H, Kimmelman AC, Lyssiotis CA, Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell. 2012; 149: 656-670.
42. Zhou W, Capello M, Fredolini C, Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells. J Proteome Res. 2010; 9: 2929-2936.
43. Cappello P, Tomaino B, Chiarle R, An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen. Int J Cancer. 2009; 125: 639-648.
44. Capello M, Ferri-Borgogno S, Cappello P, α-Enolase: a promising therapeutic and diagnostic tumor target. FEBS J. 2011; 278: 1064-1074.
45. Cui Y, Wu J, Zong M, Proteomic profiling in pancreatic cancer with and without lymph node metastasis. Int J Cancer. 2009; 124: 1614-1621.
46. Cao D, Maitra A, Saavedra JA, Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways. Mod Pathol. 2005; 18: 752-761.
47. Kawahara T, Hotta N, Ozawa Y, Quantitative proteomic profiling identifies dpysl3 as pancreatic ductal adenocarcinoma-associated molecule that regulates cell adhesion and migration by stabilization of focal adhesion complex. PLoS One. 2013; 8: e79654.
48. Yamazaki K, Takamura M, Masugi Y, Adenylate cyclase-associated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility. Lab Invest. 2009; 89: 425-432.
49. Xue X, Lu Z, Tang D, Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an in vitro study on the microenvironment of pancreatic ductal adenocarcinoma. Pancreas. 2011; 40: 832-839.
50. Van den Broeck A, Vankelecom H, Van Eijsden R, Molecular markers associated with outcome and metastasis in human pancreatic cancer. J Exp Clin Cancer Res. 2012; 31: 68.
51. Tian R, Wei LM, Qin RY, Proteome analysis of human pancreatic ductal adenocarcinoma tissue using two-dimensional gel electrophoresis and tandem mass spectrometry for identification of disease-related proteins. Dig Dis Sci. 2008; 53: 65-72.
52. Chen KT, Kim PD, Jones KA, Potential prognostic biomarkers of pancreatic cancer. Pancreas. 2014; 43: 22-27.
53. Powers TW, Neely BA, Shao Y, Maldi imaging mass spectrometry profiling of n-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays. PLoS One. 2014; 9: e106255.
54. Britton D, Zen Y, Quaglia A, Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets. PLoS One. 2014; 9: e90948.
55. Iuga C, Seicean A, Iancu C, Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma. Proteomics. 2014; 14: 945-955.
56. Mirus JE, Zhang Y, Hollingsworth MA, Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease. Mol Cell Proteomics. 2014; 13: 3484-3496.
57. Faca VM, Song KS, Wang H, A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med. 2008; 5: e123.